Atovaquone Suspension
Product Images NDC 17856-0631

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 17856-0631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atovaquonestructure (Atovaquonestructure)

Chemical structure of Atovaquone, showing a naphthoquinone core with a cyclohexyl group and a chlorophenyl substituent.*

FDA Label Image

Image Description (Rev. 1 Label)

Label for Atovaquone oral suspension, USP delivering 750 mg per 5 mL. The label includes dosage strength, route, prescription-only status, expiration and lot placeholders, distributor ATLANTIC BIOLOGICALS CORP., a barcode, and product NDC 17856-0631.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.